Join today’s open seminar at I3A on microfluidic technologies for biomedical innovation, featuring Prof. Jaap den Toonder from TU Eindhoven.
Zaragoza, May 2026 — NANBIOSIS invites researchers, students, and professionals to attend today’s open seminar, “Microfluidic Technologies Enabling Novel Biomedical Applications,” presented by Prof. Jaap den Toonder from Eindhoven University of Technology (TU/e).
The seminar will take place today, May 6, at 12:30 PM in the I3A Seminar Room, Floor 2, Block 5, offering attendees the opportunity to explore how microfluidic technologies are advancing biomedical research and healthcare innovation.
Prof. den Toonder is Full Professor and Chair of the Microsystems section at Eindhoven University of Technology since 2013. He holds both his MSc in Applied Mathematics and PhD in Mechanical Engineering (both cum laude) from Delft University of Technology. Before joining TU/e, he worked at Philips Research Laboratories Eindhoven as Principal Scientist and Chief Technologist.
His research focuses on “making things work at small scales” by developing smart materials, innovative technological concepts, and advanced microfabrication methods for microsystems. These technologies support cutting-edge applications in health and wellbeing, particularly in microfluidic chips, organ-on-chip systems, biomedical microdevices, and soft microrobotics.
With more than 180 scientific publications, over 60 patents, and more than 65 invited lectures at international conferences, Prof. den Toonder is a leading figure in the field of microfluidics and microsystems engineering. He also serves as scientific advisor to six spin-off companies originating from his research group.
Among his major achievements, he founded and directs the Microfab/lab, a state-of-the-art TU/e facility dedicated to the fabrication and analysis of microfluidic devices, microsystems, and biological materials. He is also the recipient of two ERC Advanced Grants (2019 and 2025) and has been a Fellow of the Netherlands Academy of Engineering since 2023.
The seminar is organized by TME Lab and is open to all interested attendees.
This event represents an excellent opportunity for the broader scientific community to discover how microfluidic technologies are enabling next-generation biomedical applications, from personalized medicine to advanced disease models.
Event details:
- Speaker: Prof. Jaap den Toonder
- Title: Microfluidic Technologies Enabling Novel Biomedical Applications
- Date: May 6, 2026
- Time: 12:30 PM
- Location: I3A Seminar Room, Floor 2, Block 5
- Organizer: TME Lab
- Admission: Open seminar
What is NANBIOSIS?
The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).
If you want to collaborate with us, visit our Order Request page.
In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.
NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:
